Benchmark Botanics Stock Short Ratio
| BHHKF Stock | USD 0 0.00 0.00% |
Benchmark Botanics fundamentals help investors to digest information that contributes to Benchmark Botanics' financial success or failures. It also enables traders to predict the movement of Benchmark Pink Sheet. The fundamental analysis module provides a way to measure Benchmark Botanics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Benchmark Botanics pink sheet.
Benchmark |
Benchmark Botanics Company Short Ratio Analysis
Benchmark Botanics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Benchmark Botanics has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Benchmark Fundamentals
| Return On Equity | -11.56 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (18.13) % | |||
| Current Valuation | 6.45 M | |||
| Shares Outstanding | 58.99 M | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 4.61 X | |||
| Revenue | 1.01 M | |||
| Gross Profit | (62.33 K) | |||
| EBITDA | (12.61 M) | |||
| Net Income | (10.06 M) | |||
| Cash And Equivalents | 273.03 K | |||
| Total Debt | 8.08 M | |||
| Debt To Equity | 1.50 % | |||
| Current Ratio | 0.13 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.73 M) | |||
| Earnings Per Share | (0.39) X | |||
| Beta | 0.99 | |||
| Market Capitalization | 1.75 M | |||
| Total Asset | 6.52 M | |||
| Z Score | -3.3 | |||
| Net Asset | 6.52 M |
About Benchmark Botanics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Benchmark Botanics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Benchmark Botanics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Benchmark Botanics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Benchmark Pink Sheet
Benchmark Botanics financial ratios help investors to determine whether Benchmark Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Benchmark with respect to the benefits of owning Benchmark Botanics security.